315 results on '"Ritz, Eberhard"'
Search Results
2. Aldosterone and the kidney: a rapidly moving frontier (an update)
3. Introduction to ‘Integration of the response to dietary potassium load: a paleolithic perspectiveʼ
4. Homoarginine, kidney function and cardiovascular mortality risk
5. Effects of paricalcitol on calcium and phosphate metabolism and markers of bone health in patients with diabetic nephropathy: results of the VITAL study
6. Uric acid and chronic kidney disease: which is chasing which?
7. Vascular calcification—is aldosterone a culprit?
8. Prevalence of microalbuminuria in type 2 diabetes: lessons learned from the ROADMAP study
9. High salt intake causes adverse fetal programming—vascular effects beyond blood pressure
10. Salt intake in kidney disease—a missed therapeutic opportunity?
11. Impact of oral calcium on mortality of dialysis patients—an underestimated risk?
12. Salt appetite and addiction—unholy twins?
13. Reply
14. Vitamin D status and mortality in chronic kidney disease
15. Renal denervation: potential impact on hypertension in kidney disease?
16. Vitamin D status and clinical outcomes in incident dialysis patients: results from the NECOSAD study
17. Special feature on the occasion of the 25th anniversary of NDT
18. The five most cited NDT articles from 1993 to 1999
19. Strict glycaemic control in diabetic patients with CKD or ESRD: beneficial or deadly?
20. African Americans compared to Senegalese—same number of glomeruli, but greater glomerular size. What does this tell us?
21. Control of sympathetic activity—new insights; new therapeutic targets?
22. Increased renoprotection with ACE inhibitor plus aldosterone antagonist as compared to monotherapies—the effect on podocytes
23. The association between parathyroid hormone and mortality in dialysis patients is modified by wasting
24. Arterial calcification in patients with chronic kidney disease
25. Aldosterone, a vasculotoxic agent–-novel functions for an old hormone
26. Letter to the editor regarding ‘Acute phase reaction to gadolinium-DTPA in dialysis patients’
27. Acute phase reaction to gadolinium-DTPA in dialysis patients
28. Hermann Senator and albuminuria—forgotten pioneering work in the 19th century
29. The message for World Kidney Day 2009: Hypertension and kidney disease: a marriage that should be prevented
30. Calcitriol ameliorates capillary deficit and fibrosis of the heart in subtotally nephrectomized rats
31. Salt—friend or foe?
32. Comprehensive immunohistological analysis of the endothelin system in human kidney grafts
33. Late referral – a major cause of poor outcome in the very elderly dialysis patient
34. An oral load of the early glycation compound lactuloselysine fails to accumulate in the serum of uraemic patients
35. Effects of smoking on renal function in patients with type 1 and type 2 diabetes mellitus
36. Salt-sensitive blood pressure—an intermediate phenotype predisposing to diabetic nephropathy?
37. Managing anaemia and diabetes: a future challenge for nephrologists
38. Why patients with progressing kidney disease are referred late to the nephrologist: on causes and proposals for improvement
39. Clostridium difficile diarrhoea in the immunosuppressed patient—update on prevention and management
40. Modulation of gene expression by moxonidine in rats with chronic renal failure
41. Managing mineral balance in end-stage renal disease
42. No aggravation of renal injury in apolipoprotein E knockout mice (ApoE−/−) after subtotal nephrectomy
43. Proteinuria after renal transplantation: pathogenesis and management
44. Cardiovascular complications in the diabetic patient with renal disease: an update in 2003
45. EFFECTS OF LOW-DOSE SYMPATHOLYTIC TREATMENT ON CARDIOVASCULAR STRUCTURES IN EXPERIMENTAL RENAL FAILURE
46. ROLE OF PODOCYTES AND GLOMERURULAR CAPILLARIES IN REVERSAL OF GLOMERULOSCLEROSIS
47. HYPERPHOSPHATAEMIA INCREASES THE RISK OF CHROMOSOMAL ABERRATIONS IN PARATHYROID NODULES OF URAEMIC PATIENTS
48. UREMIC PATIENTS - LATE REFERRAL, EARLY DEATH?
49. COMPARISON OF THE RENOPROTECTIVE EFFECT OF AN ENDOTHELIN RECEPTOR BLOCKER AND AN ACE INHIBITOR IN A MODEL OF DIABETIC NEPHROPATHY
50. THE EFFECT OF ESTROGENS ON INDICES OF RENAL DAMAGE IN A MODEL OF SPONTANEOUS GLOMERULOSCLEROSIS
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.